Continuous grinding kinetics of ethenzamide particles by fluidized-bed jet-milling

T. Fukunaka, B. Golman, K. Shinohara

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Continuous grinding kinetics of Ethenzamide powder, as a model active pharmaceutical ingredient (API) was investigated by fluidized-bed jet-milling. Because the oversize fractions after the classification were well fitted by a modified Rosin-Rammler distribution function, an equation of grade efficiency curve was obtained, which was also characteristic of API. A continuous grinding model was developed on the basis of a batch model by using 1st Kapur function relating grinding rate, the grade efficiency curve, and the overall process flow model consisting of grinding, classification, and mixing zones. The residual ratio obtained was well fitted to the experimental results except for the particle size range smaller than 4 μm and larger than 100 μm. Furthermore, because the volume of the active grinding zone adopted as the fitting parameter was found to be 5 cm3 in all experiments and the value was considered to be appropriate dimensionally, this result supports the reliability of the model.

Original languageEnglish
Pages (from-to)347-355
Number of pages9
JournalDrug Development and Industrial Pharmacy
Volume32
Issue number3
DOIs
Publication statusPublished - 2006
Externally publishedYes

Fingerprint

Fluidized beds
Kinetics
Particle Size
Reproducibility of Results
Pharmaceutical Preparations
Powders
Distribution functions
Particle size
ethenzamide
Experiments
rosin

Keywords

  • Continuous grinding
  • Ethenzamide
  • Fluidized-bed jet-mill
  • Kinetics
  • Mathematical model

ASJC Scopus subject areas

  • Molecular Medicine
  • Organic Chemistry
  • Drug Discovery
  • Pharmacology

Cite this

Continuous grinding kinetics of ethenzamide particles by fluidized-bed jet-milling. / Fukunaka, T.; Golman, B.; Shinohara, K.

In: Drug Development and Industrial Pharmacy, Vol. 32, No. 3, 2006, p. 347-355.

Research output: Contribution to journalArticle

@article{4fdd2008a5e74e78b76b96d5ff14f4a3,
title = "Continuous grinding kinetics of ethenzamide particles by fluidized-bed jet-milling",
abstract = "Continuous grinding kinetics of Ethenzamide powder, as a model active pharmaceutical ingredient (API) was investigated by fluidized-bed jet-milling. Because the oversize fractions after the classification were well fitted by a modified Rosin-Rammler distribution function, an equation of grade efficiency curve was obtained, which was also characteristic of API. A continuous grinding model was developed on the basis of a batch model by using 1st Kapur function relating grinding rate, the grade efficiency curve, and the overall process flow model consisting of grinding, classification, and mixing zones. The residual ratio obtained was well fitted to the experimental results except for the particle size range smaller than 4 μm and larger than 100 μm. Furthermore, because the volume of the active grinding zone adopted as the fitting parameter was found to be 5 cm3 in all experiments and the value was considered to be appropriate dimensionally, this result supports the reliability of the model.",
keywords = "Continuous grinding, Ethenzamide, Fluidized-bed jet-mill, Kinetics, Mathematical model",
author = "T. Fukunaka and B. Golman and K. Shinohara",
year = "2006",
doi = "10.1080/03639040500519136",
language = "English",
volume = "32",
pages = "347--355",
journal = "Drug Development and Industrial Pharmacy",
issn = "0363-9045",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Continuous grinding kinetics of ethenzamide particles by fluidized-bed jet-milling

AU - Fukunaka, T.

AU - Golman, B.

AU - Shinohara, K.

PY - 2006

Y1 - 2006

N2 - Continuous grinding kinetics of Ethenzamide powder, as a model active pharmaceutical ingredient (API) was investigated by fluidized-bed jet-milling. Because the oversize fractions after the classification were well fitted by a modified Rosin-Rammler distribution function, an equation of grade efficiency curve was obtained, which was also characteristic of API. A continuous grinding model was developed on the basis of a batch model by using 1st Kapur function relating grinding rate, the grade efficiency curve, and the overall process flow model consisting of grinding, classification, and mixing zones. The residual ratio obtained was well fitted to the experimental results except for the particle size range smaller than 4 μm and larger than 100 μm. Furthermore, because the volume of the active grinding zone adopted as the fitting parameter was found to be 5 cm3 in all experiments and the value was considered to be appropriate dimensionally, this result supports the reliability of the model.

AB - Continuous grinding kinetics of Ethenzamide powder, as a model active pharmaceutical ingredient (API) was investigated by fluidized-bed jet-milling. Because the oversize fractions after the classification were well fitted by a modified Rosin-Rammler distribution function, an equation of grade efficiency curve was obtained, which was also characteristic of API. A continuous grinding model was developed on the basis of a batch model by using 1st Kapur function relating grinding rate, the grade efficiency curve, and the overall process flow model consisting of grinding, classification, and mixing zones. The residual ratio obtained was well fitted to the experimental results except for the particle size range smaller than 4 μm and larger than 100 μm. Furthermore, because the volume of the active grinding zone adopted as the fitting parameter was found to be 5 cm3 in all experiments and the value was considered to be appropriate dimensionally, this result supports the reliability of the model.

KW - Continuous grinding

KW - Ethenzamide

KW - Fluidized-bed jet-mill

KW - Kinetics

KW - Mathematical model

UR - http://www.scopus.com/inward/record.url?scp=33645308519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645308519&partnerID=8YFLogxK

U2 - 10.1080/03639040500519136

DO - 10.1080/03639040500519136

M3 - Article

C2 - 16556539

AN - SCOPUS:33645308519

VL - 32

SP - 347

EP - 355

JO - Drug Development and Industrial Pharmacy

JF - Drug Development and Industrial Pharmacy

SN - 0363-9045

IS - 3

ER -